Related references
Note: Only part of the references are listed.Elevated serum YKL-40 correlates with clinical characteristics in patients with polymyositis or dermatomyositis
Ming-Zhu Gao et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2019)
Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation
Judith Wienke et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis
Lucie Andres Cerezo et al.
CYTOKINE (2019)
Serum-soluble TRAIL: a potential biomarker for disease activity in myositis patients
Hang Zhou et al.
CLINICAL RHEUMATOLOGY (2019)
The roles of neutrophil serine proteinases in idiopathic inflammatory myopathies
Siming Gao et al.
ARTHRITIS RESEARCH & THERAPY (2018)
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index
Gabriele Valentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Detection of human neutrophil elastase (HNE) on wound dressings as marker of inflammation
Ana V. Ferreira et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2017)
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Rohit Aggarwal et al.
ARTHRITIS & RHEUMATOLOGY (2017)
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
Ingrid E. Lundberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Using multi-omics methods to understand dermatomyositis/polymyositis
Siming Gao et al.
AUTOIMMUNITY REVIEWS (2017)
The role and mechanism of cathepsin G in dermatomyositis
Siming Gao et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable
Roy M. Fleischmann et al.
RMD OPEN (2017)
Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2
Milind M. Muley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Immunotherapies for Immune-Mediated Myopathies: A Current Perspective
Merrilee Needham et al.
NEUROTHERAPEUTICS (2016)
Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial
Jost Langhorst et al.
JOURNAL OF CROHNS & COLITIS (2016)
Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis
Li Zhang et al.
PLOS ONE (2016)
Dermatomyositis, polymyositis and immune-mediated necrotising myopathies
Yue-Bei Luo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is Underestimated
Beverley Almeida et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Correlation of CXCL10, Tumor Necrosis Factor Receptor Type II, and Galectin 9 With Disease Activity in Juvenile Dermatomyositis
F. Bellutti Enders et al.
ARTHRITIS & RHEUMATOLOGY (2014)
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
Dragana Lazarevic et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness
Sree Rayavarapu et al.
SKELETAL MUSCLE (2013)
Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China
Xiao Ming Shu et al.
BMC NEUROLOGY (2011)
The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
Chee-Seng Yee et al.
RHEUMATOLOGY (2011)
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
Brice Korkmaz et al.
PHARMACOLOGICAL REVIEWS (2010)
Elevated Serum Concentrations of Polymorphonuclear Neutrophilic Leukocyte Elastase in Systemic Sclerosis: Association with Pulmonary Fibrosis
Toshihide Hara et al.
JOURNAL OF RHEUMATOLOGY (2009)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease
DA Isenberg et al.
RHEUMATOLOGY (2004)
The role of neutrophil elastase in acute lung injury
K Kawabata et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Share Paper
